recent, American company10x GenomicsA request was submitted to the Local Branch in Dusseldorf, Demand from its competitorsCurio BioscienceGrant a preliminary injunction. merely, The defendant did not choose a local lawyer, But letCarpmaels & RansfordThe law firm is representing him. The case marks the first time a UK law firm has been fully independent before the Unified Patent Court (UPC) Filed a lawsuit.

inUPC, From America10X GenomicsallegeCurio BioscienceInfringed its European patent (Number asEP2697391) , The patent protects a method and product for local or spatial detection of nucleic acids in tissue samples.

Last year12month, The company filed a complaint with the regional court in DusseldorfCurio Biosciencethe "Seeker Spatial Transcriptomics Kits (Explorer space transcriptome kit) " For a preliminary injunction. These kits can spatially map the entire transcriptome of a tissue. 10X GenomicstheVisiumThe platform uses a similar spatial transcriptome technique. At the time of the application, 10X GenomicsWant to stop each other in Germany, Sales operations in France and Sweden.

According to multiple reports in the US media, 12Beginning of month, 10X GenomicsIn the United States District Court for the District of DelawareCurio BioscienceMultiple patents. At present, The American biotechnology company doesn't seem to be paying too much attention to its longtime rivalNanoString, It's against another competitor.

10x GenomicsinUPCThe performance is more active

Biotechnology company10X GenomicsBe atUPCOne of the most active plaintiffs in the US. inUPCFirst day of trial, The company has a local branch in Munich to its competitorsNanoStringFiled a lawsuit, It was followed by a branch in HamburgVizgenAnother lawsuit was filed.

At present, A trial is underway in Munich againstNanoStringTwo requests for preliminary injunctions and two lawsuits filed, The request for a preliminary injunction is of particular concern.

prime, The local branch of Munich did not want to follow10x GenomicsTo request a preliminary injunction. however, The court granted a second request for preliminary injunction, And requestNanoStringDiscontinued in EuropeCosMxSpace molecular imaging instrument (SMI) As well as forRNAdetectingCosMxreagent.

however, in2End of month, UPCThe appeals court overturned a preliminary injunction by the Munich District Court. The decision allowsNanoStringReturn to most European markets, And that's where the Court of Appeal isUPCThe first judgment rendered in the proceedings.

Set a precedent

therefrom, UPCThe Supreme Court of the United States of America has laid down some far-reaching principles for the preliminary injunction process. These principles played an important role in the oral hearings held in Dusseldorf. therefore, UPCThe judge must be fully aware, Even though they issued a preliminary injunction, But the patents in question are probably still valid. therefore, When the charges were dropped, There is a higher probability that the patent will have to be maintained in litigation.

So far, People don't know yet10X GenomicsIs it already inUPCrightCurio BioscienceFiled a lawsuit, Or forEP2697391Whether the revocation of the patent is pending. The patent is not currently in connection withNanoStringandVizgenProduce influence in disputes. (Be compiled fromwww. juve-patent. com)

TRANSLATORS: Liu Peng　proofread: Wu Xian



　　disclaimer: This network reprint or compile the original articles are from the network, Does not represent the views of this website or confirm the authenticity of its content. If the source is mislabeled or the copyright of the article is involved, Please contact us, This website will be corrected in due course, delete, thank you.